TY - JOUR AU - Folkman, J. PY - 1995 DA - 1995// TI - Angiogenesis in cancer, vascular, rheumatoid and other disease JO - Nat Med VL - 1 UR - https://doi.org/10.1038/nm0195-27 DO - 10.1038/nm0195-27 ID - Folkman1995 ER - TY - JOUR AU - Hanahan, D. AU - Folkman, J. PY - 1996 DA - 1996// TI - Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis JO - Cell VL - 86 UR - https://doi.org/10.1016/S0092-8674(00)80108-7 DO - 10.1016/S0092-8674(00)80108-7 ID - Hanahan1996 ER - TY - JOUR AU - Pasquier, E. AU - Kavallaris, M. AU - André, N. PY - 2010 DA - 2010// TI - Metronomic chemotherapy: new rationale for new directions JO - Nat Rev Clin Oncol VL - 7 UR - https://doi.org/10.1038/nrclinonc.2010.82 DO - 10.1038/nrclinonc.2010.82 ID - Pasquier2010 ER - TY - JOUR AU - Ferrara, N. AU - Kerbel, R. S. PY - 2005 DA - 2005// TI - Angiogenesis as a therapeutic target JO - Nature VL - 438 UR - https://doi.org/10.1038/nature04483 DO - 10.1038/nature04483 ID - Ferrara2005 ER - TY - JOUR AU - Carmeliet, P. AU - Jain, R. K. PY - 2011 DA - 2011// TI - Molecular mechanisms and clinical applications of angiogenesis JO - Nature VL - 473 UR - https://doi.org/10.1038/nature10144 DO - 10.1038/nature10144 ID - Carmeliet2011 ER - TY - JOUR AU - Mina-Osorio, P. PY - 2008 DA - 2008// TI - The moonlighting enzyme CD13: old and new functions to target JO - Trends Mol Med VL - 14 UR - https://doi.org/10.1016/j.molmed.2008.06.003 DO - 10.1016/j.molmed.2008.06.003 ID - Mina-Osorio2008 ER - TY - JOUR AU - Corti, A. AU - Curnis, F. AU - Rossoni, G. AU - Marcucci, F. AU - Gregorc, V. PY - 2013 DA - 2013// TI - Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example JO - BioDrugs VL - 27 UR - https://doi.org/10.1007/s40259-013-0048-z DO - 10.1007/s40259-013-0048-z ID - Corti2013 ER - TY - JOUR AU - Pasqualini, R. AU - Koivunen, E. AU - Kain, R. AU - Lahdenranta, J. AU - Sakamoto, M. AU - Stryhn, A. PY - 2000 DA - 2000// TI - Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis JO - Cancer Res VL - 60 ID - Pasqualini2000 ER - TY - JOUR AU - Fukasawa, K. AU - Fujii, H. AU - Saitoh, Y. AU - Koizumi, K. AU - Aozuka, Y. AU - Sekine, K. PY - 2006 DA - 2006// TI - Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis JO - Cancer Lett VL - 243 UR - https://doi.org/10.1016/j.canlet.2005.11.051 DO - 10.1016/j.canlet.2005.11.051 ID - Fukasawa2006 ER - TY - JOUR AU - Arap, W. AU - Pasqualini, R. AU - Ruoslahti, E. PY - 1998 DA - 1998// TI - Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model JO - Science VL - 279 UR - https://doi.org/10.1126/science.279.5349.377 DO - 10.1126/science.279.5349.377 ID - Arap1998 ER - TY - JOUR AU - Ellerby, H. M. AU - Arap, W. AU - Ellerby, L. M. AU - Kain, R. AU - Andrusiak, R. AU - Rio, G. D. PY - 1999 DA - 1999// TI - Anti-cancer activity of targeted pro-apoptotic peptides JO - Nat Med VL - 5 UR - https://doi.org/10.1038/12469 DO - 10.1038/12469 ID - Ellerby1999 ER - TY - JOUR AU - Persigehl, T. AU - Ring, J. AU - Bremer, C. AU - Heindel, W. AU - Holtmeier, R. AU - Stypmann, J. PY - 2014 DA - 2014// TI - Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imaging JO - Angiogenesis VL - 17 UR - https://doi.org/10.1007/s10456-013-9391-4 DO - 10.1007/s10456-013-9391-4 ID - Persigehl2014 ER - TY - JOUR AU - Bieker, R. AU - Kessler, T. AU - Schwöppe, C. AU - Padró, T. AU - Persigehl, T. AU - Bremer, C. PY - 2009 DA - 2009// TI - Infarction of tumor vessels by NGR-peptide-directed targeting of tissue factor: experimental results and first-in-man experience JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-04-150318 DO - 10.1182/blood-2008-04-150318 ID - Bieker2009 ER - TY - JOUR AU - Van Hensbergen, Y. AU - Broxterman, H. J. AU - Elderkamp, Y. W. AU - Lankelma, J. AU - Beers, J. C. AU - Heijn, M. PY - 2002 DA - 2002// TI - A doxorubicin-CNGRC-peptide conjugate with prodrug properties JO - Biochem Pharmacol VL - 63 UR - https://doi.org/10.1016/S0006-2952(01)00928-5 DO - 10.1016/S0006-2952(01)00928-5 ID - Van Hensbergen2002 ER - TY - JOUR AU - Von Wallbrunn, A. AU - Waldeck, J. AU - Höltke, C. AU - Zühlsdorf, M. AU - Mesters, R. AU - Heindel, W. PY - 2008 DA - 2008// TI - In vivo optical imaging of CD13/APN-expression in tumor xenografts JO - J Biomed Opt VL - 13 UR - https://doi.org/10.1117/1.2839046 DO - 10.1117/1.2839046 ID - Von Wallbrunn2008 ER - TY - JOUR AU - Hahnenkamp, A. AU - Schäfers, M. AU - Bremer, C. AU - Höltke, C. PY - 2013 DA - 2013// TI - Design and synthesis of small-molecule fluorescent photoprobes targeted to aminopeptdase N (APN/CD13) for optical imaging of angiogenesis JO - Bioconjug Chem VL - 24 UR - https://doi.org/10.1021/bc400074w DO - 10.1021/bc400074w ID - Hahnenkamp2013 ER - TY - JOUR AU - Guillen, K. P. AU - Kurkjian, C. AU - Harrison, R. G. PY - 2014 DA - 2014// TI - Targeted enzyme prodrug therapy for metastatic prostate cancer - a comparative study of L-methioninase, purine nucleoside phosphorylase, and cytosine deaminase JO - J Biomed Sci VL - 21 UR - https://doi.org/10.1186/s12929-014-0065-3 DO - 10.1186/s12929-014-0065-3 ID - Guillen2014 ER - TY - JOUR AU - Van Rite, B. D. AU - Harrison, R. G. PY - 2011 DA - 2011// TI - Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine JO - Cancer Lett VL - 307 UR - https://doi.org/10.1016/j.canlet.2011.03.016 DO - 10.1016/j.canlet.2011.03.016 ID - Van Rite2011 ER - TY - JOUR AU - Miller, C. R. AU - Williams, C. R. AU - Buchsbaum, D. J. AU - Gillespie, G. Y. PY - 2002 DA - 2002// TI - Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas JO - Cancer Res VL - 62 ID - Miller2002 ER - TY - JOUR AU - Lan, K. H. AU - Shih, Y. S. AU - Chang, C. A. AU - Yen, S. H. AU - Lan, K. L. PY - 2012 DA - 2012// TI - 5-Fluorocytosine combined with Fcy-hEGF fusion protein targets EGFR-expressing cancer cells JO - Biochem Biophys Res Commun VL - 428 UR - https://doi.org/10.1016/j.bbrc.2012.10.050 DO - 10.1016/j.bbrc.2012.10.050 ID - Lan2012 ER - TY - JOUR AU - Hamstra, D. A. AU - Rice, D. J. AU - Fahmy, S. AU - Ross, B. D. AU - Rehemtulla, A. PY - 1999 DA - 1999// TI - Enzyme/Prodrug Therapy for Head and Neck Cancer Using a Catalytically Superior Cytosine Deaminase JO - Hum Gene Ther VL - 10 UR - https://doi.org/10.1089/10430349950017356 DO - 10.1089/10430349950017356 ID - Hamstra1999 ER - TY - JOUR AU - Kievit, E. AU - Bershad, E. AU - Ng, E. AU - Sethna, P. AU - Dev, I. AU - Lawrence, T. S. PY - 1999 DA - 1999// TI - Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts JO - Cancer Res VL - 59 ID - Kievit1999 ER - TY - JOUR AU - Nyati, M. K. AU - Symon, Z. AU - Kievit, E. AU - Dornfeld, K. J. AU - Rynkiewicz, S. D. AU - Ross, B. D. PY - 2002 DA - 2002// TI - The potential of 5-fluorocytosine/cytosine deaminase enzyme prodrug gene therapy in an intrahepatic colon cancer model JO - Gene Ther VL - 9 UR - https://doi.org/10.1038/sj.gt.3301706 DO - 10.1038/sj.gt.3301706 ID - Nyati2002 ER - TY - JOUR AU - Lv, S. Q. AU - Zhang, K. B. AU - Zhang, E. E. AU - Gao, F. Y. AU - Yin, C. L. AU - Huang, C. J. PY - 2009 DA - 2009// TI - Antitumor efficiency of the cytosine deaminase/5-fluorocytosine suicide gene therapy system on malignant gliomas: an in vivo study JO - Med Sci Monit VL - 15 ID - Lv2009 ER - TY - JOUR AU - Chen, C. T. AU - Yamaguchi, H. AU - Lee, H. J. AU - Du, Y. AU - Lee, H. H. AU - Xia, W. PY - 2011 DA - 2011// TI - Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase JO - Mol Cancer Ther VL - 10 UR - https://doi.org/10.1158/1535-7163.MCT-10-1117 DO - 10.1158/1535-7163.MCT-10-1117 ID - Chen2011 ER - TY - JOUR AU - Bhagwat, S. V. AU - Lahdenranta, J. AU - Giordano, R. AU - Arap, W. AU - Pasqualini, R. AU - Shapiro, L. H. PY - 2001 DA - 2001// TI - CD13/APN is activated by angiogenic signals and is essential for capillary tube formation JO - Blood VL - 97 UR - https://doi.org/10.1182/blood.V97.3.652 DO - 10.1182/blood.V97.3.652 ID - Bhagwat2001 ER - TY - JOUR AU - Majumdar, S. AU - Siahaan, T. J. PY - 2012 DA - 2012// TI - Peptide-mediated targeted drug delivery JO - Med Res Rev VL - 32 UR - https://doi.org/10.1002/med.20225 DO - 10.1002/med.20225 ID - Majumdar2012 ER - TY - JOUR AU - Chen, L. AU - Lin, Y. L. AU - Peng, G. AU - Li, F. PY - 2012 DA - 2012// TI - Structural basis for multifunctional roles of mammalian aminopeptidase N JO - Proc Natl Acad Sci U S A VL - 109 UR - https://doi.org/10.1073/pnas.1210123109 DO - 10.1073/pnas.1210123109 ID - Chen2012 ER - TY - JOUR AU - Wickström, M. AU - Larsson, R. AU - Nygren, P. AU - Gullbo, J. PY - 2011 DA - 2011// TI - Aminopeptidase N (CD13) as a target for cancer chemotherapy JO - Cancer Sci VL - 102 UR - https://doi.org/10.1111/j.1349-7006.2010.01826.x DO - 10.1111/j.1349-7006.2010.01826.x ID - Wickström2011 ER - TY - JOUR AU - Liu, C. AU - Yang, Y. AU - Chen, L. AU - Lin, Y. L. AU - Li, F. PY - 2014 DA - 2014// TI - A unified mechanism for aminopeptidase N-based tumor cell motility and tumor-homing therapy JO - J Biol Chem VL - 289 UR - https://doi.org/10.1074/jbc.M114.566802 DO - 10.1074/jbc.M114.566802 ID - Liu2014 ER - TY - JOUR AU - Curnis, F. AU - Arrigoni, G. AU - Sacchi, A. AU - Fischetti, L. AU - Arap, W. AU - Pasqualini, R. PY - 2002 DA - 2002// TI - Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells JO - Cancer Res VL - 62 ID - Curnis2002 ER - TY - JOUR AU - Curnis, F. AU - Sacchi, A. AU - Borgna, L. AU - Magni, F. AU - Gasparri, A. AU - Corti, A. PY - 2000 DA - 2000// TI - Enhancement of tumor necrosis factor alpha antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13) JO - Nat Biotechnol VL - 18 UR - https://doi.org/10.1038/81183 DO - 10.1038/81183 ID - Curnis2000 ER - TY - JOUR AU - Corti, A. AU - Curnis, F. PY - 2011 DA - 2011// TI - Tumor vasculature targeting through NGR peptide-based drug delivery systems JO - Curr Pharm Biotechnol VL - 12 UR - https://doi.org/10.2174/138920111796117373 DO - 10.2174/138920111796117373 ID - Corti2011 ER - TY - JOUR AU - Longley, D. B. AU - Harkin, D. P. AU - Johnston, P. G. PY - 2003 DA - 2003// TI - 5-fluorouracil: mechanisms of action and clinical strategies JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1074 DO - 10.1038/nrc1074 ID - Longley2003 ER -